CD28, a marker associated with tumoral expansion in multiple myeloma

Clinical Cancer Research

Volumn 4, Issue 6, 1998, Pages 1521-1526

  Robillard, Nelly ^a   Jego, Gaétan ^a   Pellat Deceunynck, Catherine ^a   Pineau, Danielle ^a   Puthier, Denis ^a   Mellerin, Marie Paule ^a   Barillé, Sophie ^a   Rapp, Marie José ^a   Harousseau, Jean Luc ^a   Amiot, Martine ^a   Bataille, Régis ^a  

^a INSTITUT DE BIOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD86 ANTIGEN;

ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; DIAGNOSTIC VALUE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; MYELOMA CELL; PLASMA CELL; PRIORITY JOURNAL; PROGNOSIS;

ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD56; ANTIGENS, CD80; ANTIGENS, CD86; BONE MARROW; CELL LINE; DISEASE PROGRESSION; HUMANS; LEUKEMIA, PLASMACYTIC; MEMBRANE GLYCOPROTEINS; MULTIPLE MYELOMA; NEOPLASMS, SECOND PRIMARY; PARAPROTEINEMIAS; PREDICTIVE VALUE OF TESTS; RECURRENCE; TREATMENT FAILURE; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 17344378375     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Linsley, P. S., and Ledbetter, J. A. The role of the CD28 receptor during cell responses to antigen. Annu. Rev. Immunol., 11: 191-212, 1993.
2. Rudd, C. E., Janssen, O., Cai, Y. C., Da Silva, A. J., Raab, M., and Prasad, K. V. S. Two-step TCR CD3-CD4, and CD28 signaling in T cells. SH2/SH3 domains, protein tyrosine and lipid kinases. Immunol. Today, 15: 225-234, 1994.
3. June, C. H., Bluestone, J. A., Nadler, L. M., and Thompson, C. B. The B7 and CD28 receptor families. Immunol. Today, 15: 321-337, 1994.
4. Guinan, E. C., Gribben, J. G., Boussiotis, V. A., Freeman, G. J., and Nadler, L. M. Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity. Blood, 84: 3261-3282, 1994.
5. Kozbor, D., Moretta, A., Messner, H. A., Moretta, L., and Croce, C. M. Tp44 molecules involved in antigen-independent T cell activation are expressed on human plasma cells. J. Immunol., 138: 4128-4132, 1987.
6. Lee, K. P., Taylor, C., Petryniak, B., Turka, L. A., June, C. H., and Thompson, C. B. The genomic organization of the CD28 gene: implications for the regulation of CD28 mRNA expression and heterogeneity. J. Immunol., 145: 344-352, 1989.
7. Pellat-Deceunynck, C., Bataille, R., Robillard, N, Harousseau, J. L., Rapp, M. J., Juge-Morineau, N., Wijdenes, J., and Amiot, M. Expression of CD28 and CD40 in human myeloma cells: a comparative study with normal plasma cells. Blood, 84: 2597-2603, 1994.
8. Zhang, X. G., Gaillard, J. P., Robillard, N., Lu, Z. Y., Gu, Z. J., Jourdan, M., Boiron, J. M., Bataille, R., and Klein, B. Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma. Blood, 83: 3654-3663, 1994.
9. Pellat-Deceunynck, C., Amiot, M., Bataille, R., Van Riet, Y., Van Camp, B., Omede, P., and Boccadoro, M. Human myeloma cell lines as a tool for studying the biology of multiple myeloma: a reappraisal 18 years after. Blood, 86: 4001-4002, 1995.
10. Bataille, R., Chappard, D., and Basle, M. F. Quantifiable excess of bone resorption in monoclonal gammopathy is an early symptom of malignancy: a prospective study of 87 bone biopsies. Blood, 87: 4762-4769, 1996.
11. Durie, B. G. M., and Salmon, S. E. Multiple myeloma, macroglobulinaemia and monoclonal gammopathies. In: A. V. Hoffbrand, M. C. Brain, and J. Hish (eds.), Recent Advances in Haematology, pp. 243-261, 1977.
12. Barillé, S., Akhoundi, C., Colette, M., Mellerin, M. P., Rapp, M. J., Harousseau, J. L., Bataille, R., and Amiot, M. Metalloproteinases in multiple myeloma. Production of matrix metalloproteinase-9 (MMP-9), activation of proMMP-2 and induction of MMP-1 by myeloma cells. Blood, 90: 1649-1655, 1997.
13. Wijdenes, J., Vooijs, W. C., Clement, C., Post, J., Morard, F., Vita, N., Laurent, P., Sun, R. X., Klein, B., and Dore, J. M. A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1. Br. J. Haematol., 94: 318-323, 1996.
14. Carayon, P., and Bord, A. Identification of DNA-replicating lymphocyte subsets using a new method to label the bromo-deoxyuridine incorporated into the DNA. J. Immunol. Methods, 147: 225-230, 1992.
15. Pellat-Deceunynck, C., Puthier, D., Rapp, M. J., Harousseau, J. L., Bataille, R., and Amiot, M. Adhesion molecules on human plasma cells: significant changes in expression related to malignant transformation, tumor spreading and immortalization. Cancer Res., 55: 3647-3653, 1995.
16. Van Camp, B., Durie, B. G. M., Spier, C., De Wade, M., Van Riet, I., Vela, E., Frutiger, Y., Richter, L., and Grogan, T. M. Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH-1; Leu-19). Blood, 76: 377-382, 1990.
17. Harada, H., Kawano, M. M., Huang, N., Harada, Y., Iwato, K., Tanabe, O., Tanaka, H., Sakai, A., Asaoku, H., and Kuramoto, A. Phenotypic difference of normal plasma cells from mature myeloma cells. Blood, 81: 2658-2663, 1993.
18. Gavarotti, P., Boccadoro, M., Redoglia, V., Golzio, F., and Pileri, A. Reactive plasmocytosis: case report and review of the literature. Acta Haematol., 73: 108-110, 1985.
19. Westendorf, J. J., Ahmann, G. J., Greipp, P. R., Witzig, T. E, Kyle, R. A., Lust, J. A., and Jelinek, D. F. Establishment and characterization of three myeloma cell lines that demonstrate variable cytokine responses and abilities to produce autocrine interleukin-6. Leukemia (Baltimore), 10: 866-876, 1996.
20. Mazars, G. R., Portier, M., Zhang, X. G., Jourdan, M., Bataille, R., Theillet, C., and Klein, B. Mutations of the p53 gene in human myeloma cell lines. Oncogene, 7: 1015-1018, 1992.
21. Portier, M., Moles, J. P., Mazars, G. R., Jeanteur, P., Bataille, R., Klein, B., and Theillet, C. p53 and Ras gene mutations in multiple myeloma. Oncogene, 7: 2539-2543, 1992.
22. L. Immunity, 3: 87-98, 1995.
23. L on activated T cells and can be prevented by CD28 costimulation. J. Immunol., 158: 598-603, 1997.
24. Tu, Y., Renner, S., Xu, F., Fleishman, A., Taylor, J., Weisz, J., Vescio, R., Rettig, M., Berenson, J., Krajewski, S., Reed, J. C., and Lichtenstein, A. Bcl-X expression in multiple myeloma: possible indicator of chemoresistance. Cancer Res., 58: 256-262, 1998.